Kyoto-shi, Japan

Takaaki Kawanobe

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Pharma Foods International Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takaaki Kawanobe. Retrieved from https://idiyas.com/inventor/takaaki-kawanobe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takaaki Kawanobe: Innovator in Antibody Development

Introduction

Takaaki Kawanobe is a prominent inventor based in Kyoto-shi, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Kawanobe holds a patent for a "Novel Anti-PAD2 Antibody." This invention represents a breakthrough in the understanding and treatment of certain medical conditions. The patent highlights his commitment to creating solutions that can potentially improve patient outcomes.

Career Highlights

Kawanobe is currently employed at Pharma Foods International Co., Ltd. His role at the company allows him to collaborate with other talented professionals in the field. His work has been instrumental in driving forward the company's research initiatives and product development.

Collaborations

Throughout his career, Kawanobe has worked alongside notable colleagues such as Tomoko Sakata and Keita Koga. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Takaaki Kawanobe is a dedicated inventor whose work in antibody development is paving the way for future advancements in biotechnology. His contributions are not only valuable to his company but also to the broader medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…